Unlock stock picks and a broker-level newsfeed that powers Wall Street. Upgrade Now
0.0001
0.0000
(0.00%)
As of March 3 at 3:00:00 PM EST. Market Open.
Insider Roster
Insider roster data is derived solely from the last 24 months of Form 3 & Form 4 SEC filings.
| Individual or Entity | Most Recent Transaction | Date | Shares Owned as of Transaction Date |
|---|---|---|---|
| BACKENROTH SAMUEL Chief Financial Officer | Conversion of Exercise of derivative security | Mar 31, 2023 | 525,000 |
| BOCK THOMAS A. M.D. Chief Executive Officer | Stock Award(Grant) | May 8, 2024 | 400,000 |
| DUBIN THOMAS I.H. Director | Stock Award(Grant) | May 8, 2024 | 40,247 |
| FEINBERG PETER Director | Stock Award(Grant) | May 8, 2024 | 40,247 |
| FR CAPITAL HOLDINGS, L.P. Beneficial Owner of more than 10% of a Class of Security | Sale | Jan 2, 2024 | -- |
| GALEN MICHELE Director | Stock Award(Grant) | May 8, 2024 | 40,247 |
| GRANEY THOMAS Director | Stock Award(Grant) | May 8, 2024 | 40,247 |
| PATSI TUOMO Director | Stock Award(Grant) | May 8, 2024 | 65,247 |
Related Tickers
ETBI Eastgate Biotech Corp.
0.0045
+4,400.01%
MDCLF MedinCell S.A.
6.98
0.00%
ATHXQ Athersys, Inc.
0.0000
0.00%
HOPHF Hemogenyx Pharmaceuticals Plc
1.2400
0.00%
ELDN Eledon Pharmaceuticals, Inc.
3.9200
-2.12%
DMAC DiaMedica Therapeutics Inc.
5.92
-4.67%
SCPX Scorpius Holdings, Inc.
0.1497
-6.49%
RZLT Rezolute, Inc.
4.0000
-3.38%
PULM Pulmatrix, Inc.
7.03
-9.76%
ATHE Alterity Therapeutics Limited
3.5800
-1.65%